Regulation

Protego Bio Secures $130M for Rare Disease Drug Trial
Business Protego Bio Secures $130M for Rare Disease Drug Trial

In a landscape where rare disease treatments often struggle to gain traction, the recent $130 million Series B financing secured by San Diego-based biotech startup Protego Biopharma stands as a beacon of potential. This substantial investment, aimed at advancing the first-in-class drug candidate

Excellence Imagerie Secures Growth Investment for Expansion
Business Excellence Imagerie Secures Growth Investment for Expansion

Imagine a healthcare landscape where cutting-edge diagnostic imaging not only saves lives but redefines patient care through precision and speed. In France, this vision is becoming a reality as diagnostic imaging emerges as a cornerstone of modern medicine. Amid this dynamic environment, Excellence

Why Is the FDA Worried About Unsecured Healthcare Software?
Data and Information Why Is the FDA Worried About Unsecured Healthcare Software?

Imagine a hospital in the midst of a critical operation when suddenly, a ransomware attack locks down its digital systems, halting access to patient records and disabling life-saving devices. This chilling scenario is not science fiction but a growing reality in today’s healthcare landscape, where t

InsiteOne Boosts Imaging with Key Strategic Partnerships
Process InsiteOne Boosts Imaging with Key Strategic Partnerships

Imagine a world where a patient's critical diagnostic images are instantly accessible to clinicians across specialties, seamlessly integrated into workflows, and securely stored in the cloud, all while enhancing care delivery. This vision is no longer a distant dream but a tangible reality

Can Advanced Practice Providers Solve the Investigator Shortage?
Public Policy Can Advanced Practice Providers Solve the Investigator Shortage?

Picture a rural clinic in South Carolina, where patients eagerly await access to cutting-edge clinical trials, only to find that the shortage of principal investigators stands as a formidable barrier between them and innovative treatments. This scene plays out across countless communities, where

TrumpRx GLP-1 Deal Cuts Costs, But Leaves Systemic Gaps
Public Policy TrumpRx GLP-1 Deal Cuts Costs, But Leaves Systemic Gaps

The sudden pairing of a government-run, direct-to-consumer channel with immediate Medicare coverage for obesity indications reshaped the GLP-1 market overnight, anchoring new price points that relieve patients today while exposing how much of the system still runs on opacity and uneven leverage.

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later